Workflow
灵康药业(603669) - 2024 Q1 - 季度财报
LioncoLionco(SH:603669)2024-04-19 13:44

Financial Performance - The company's operating revenue for Q1 2024 was ¥76,861,627.55, representing a year-on-year increase of 4.85%[5] - The net profit attributable to shareholders was a loss of ¥16,041,506.14, with a basic earnings per share of -¥0.02[5][6] - The company reported a net loss of RMB -191,962,972.41 for Q1 2024, compared to a net loss of RMB -175,921,466.27 in Q1 2023[18] - The net profit for Q1 2024 was -16,041,506.14 RMB, compared to -22,991,377.51 RMB in Q1 2023, showing an improvement of approximately 30% year-over-year[22] - Operating profit for Q1 2024 was -17,208,207.06 RMB, an improvement from -20,999,994.59 RMB in the same period last year[22] - The total comprehensive income for Q1 2024 was -16,041,506.14 RMB, compared to -22,991,377.51 RMB in Q1 2023, indicating a positive trend in overall financial performance[23] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,483,165,176.81, down 8.70% from the previous year[6] - As of March 31, 2024, total assets amounted to RMB 1,483,165,176.81, down from RMB 1,624,560,125.88 at the end of 2023[18] - Total liabilities decreased to RMB 569,816,757.99 from RMB 693,517,978.39 at the end of 2023, reflecting a reduction of approximately 17.8%[18] - The total equity attributable to shareholders was RMB 913,348,418.82, down from RMB 931,042,147.49 at the end of 2023[18] Cash Flow - The net cash flow from operating activities was -¥20,674,871.45[5] - The cash flow from operating activities in Q1 2024 was -20,674,871.45 RMB, compared to -16,867,851.74 RMB in Q1 2023, indicating a worsening cash flow situation[27] - Cash flow from investment activities in Q1 2024 was 81,217,845.65 RMB, a significant recovery from -108,914,490.26 RMB in Q1 2023[27] - The company reported a cash and cash equivalents balance of 282,930,347.78 RMB at the end of Q1 2024, down from 475,261,821.28 RMB at the end of Q1 2023[27] Shareholder Information - The company has a total of 20,779 common shareholders at the end of the reporting period[12] - The largest shareholder, Lingkang Holdings Group Co., Ltd., holds 339,652,800 shares, accounting for 47.09% of total shares[13] Operating Costs and Revenue - Total operating revenue for Q1 2024 was RMB 76,861,627.55, an increase of 7.4% compared to RMB 73,303,587.38 in Q1 2023[21] - Total operating costs for Q1 2024 were RMB 94,759,740.05, slightly decreased from RMB 94,993,229.26 in Q1 2023[21] - Operating costs included RMB 33,008,973.81 in cost of goods sold, up from RMB 27,550,894.23 in the previous year, indicating a 19.7% increase[21] - Total revenue from sales and services received in Q1 2024 was 71,723,378.82 RMB, up from 65,651,043.72 RMB in Q1 2023, representing an increase of about 9%[25] Research and Development - Research and development expenses increased to 4,772,080.07 RMB in Q1 2024 from 3,470,253.82 RMB in Q1 2023, reflecting a growth of approximately 37%[22] Financial Management - The company incurred financial expenses of -332,164.72 RMB in Q1 2024, a decrease from 107,918.44 RMB in Q1 2023, indicating improved financial management[22] - The weighted average return on net assets was -1.74%[6] - The company is focusing on improving its financial performance and reducing losses in the upcoming quarters[10]